Filing Details
- Accession Number:
- 0000904454-15-000215
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-03-17 16:41:43
- Reporting Period:
- 2015-03-17
- Filing Date:
- 2015-03-17
- Accepted Time:
- 2015-03-17 16:41:43
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1457612 | Genocea Biosciences Inc. | GNCA | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1190418 | J Stephen Hoffman | C/O Skyline Ventures 303 Wyman Street, Suite 300 Waltham MA 02451 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-03-17 | 700,000 | $8.25 | 1,992,415 | No | 4 | P | Indirect | See Footnotes |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Indirect | See Footnotes |
Footnotes
- The general partner of Skyline Venture Partners V, L.P. is Skyline Venture Management V, LLC. Stephen J. Hoffman is a director of Genocea Biosciences, Inc. (the "Issuer") and a member of Skyline Venture Partners V, L.P. To the extent that he is deemed to share voting and investment powers with respect to the shares held by Skyline Venture Partners V, L.P., Dr. Hoffman disclaims beneficial ownership of all such shares and this report shall not be deemed an admission of beneficial ownership for purposes of Section 16 or for any other purposes, except to the extent of his proportionate pecuniary interest therein.
- Upon the closing of the Issuer's public offering, 700,000 shares of common stock were issued to Skyline Venture Partners V, L.P. at the public offering price of $8.25 per share.